285 related articles for article (PubMed ID: 11374135)
21. [The effect of cellulose diacetate dialysis membranes on lipids and lipoproteins in uremic patients].
Jakić M; Rupcić V; Stipanić S; Samardzija G; Bilandzija M; Zibar L; Mihaljević D; Milas J
Lijec Vjesn; 1997 Feb; 119(2):56-9. PubMed ID: 9297037
[TBL] [Abstract][Full Text] [Related]
22. Modification of serum and membrane lipid composition induced by diet in patients with chronic renal failure.
Loschiavo C; Ferrari S; Aprili F; Grigolini L; Faccini G; Maschio G
Clin Nephrol; 1990 Dec; 34(6):267-71. PubMed ID: 2073770
[TBL] [Abstract][Full Text] [Related]
23. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
[TBL] [Abstract][Full Text] [Related]
24. Oxidative stress in hemodialysis--postdialytic changes.
Dakshinamurty KV; Rao PV; Saibaba KS; Sheela RB; Sreekrishna V; Venakataramana G; Shyam C; Jayaseelan L
Clin Lab; 2003; 49(5-6):255-61. PubMed ID: 15285183
[TBL] [Abstract][Full Text] [Related]
25. Effect of uremia and hemodialysis on soluble L-selectin and leukocyte surface CD11b and L-selectin.
Dou L; Brunet P; Dignat-George F; Sampol J; Berland Y
Am J Kidney Dis; 1998 Jan; 31(1):67-73. PubMed ID: 9428454
[TBL] [Abstract][Full Text] [Related]
26. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
27. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure].
Starzyk J; Bartelik S; Sarnecka S
Wiad Lek; 1994 Jul; 47(13-14):523-6. PubMed ID: 7716940
[TBL] [Abstract][Full Text] [Related]
28. Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow-up study.
Diop ME; Viron B; Bailleul S; Lefevre G; Fessi H; Maury J; Etienne J; Couderc R
Clin Nephrol; 2000 Sep; 54(3):210-7. PubMed ID: 11020019
[TBL] [Abstract][Full Text] [Related]
29. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
30. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
[TBL] [Abstract][Full Text] [Related]
31. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis.
Lucchi L; Iannone A; Bergamini S; Stipo L; Perrone S; Uggeri S; Gatti V; Ferrari F; Tomasi A; Albertazzi A
Artif Organs; 2005 Oct; 29(10):832-7. PubMed ID: 16185346
[TBL] [Abstract][Full Text] [Related]
32. Granulocyte activation during hemodialysis.
Hörl WH; Riegel W; Steinhauer HB; Wanner C; Thaiss F; Bozkurt F; Haag M; Schollmeyer P
Clin Nephrol; 1986; 26 Suppl 1():S30-4. PubMed ID: 3829465
[TBL] [Abstract][Full Text] [Related]
33. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
[TBL] [Abstract][Full Text] [Related]
34. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.
Thalhammer F; Rosenkranz AR; Burgmann H; Graninger W; Hollenstein U; Schenk P; Thalhammer-Scherrer R; Traindl O; Hörl WH; Breyer S
Wien Klin Wochenschr; 1997 May; 109(10):362-5. PubMed ID: 9200809
[TBL] [Abstract][Full Text] [Related]
35. [Phospholipid composition of erythrocytes in patients with chronic kidney failure].
Akalaev RN; Abidov AA
Vopr Med Khim; 1993; 39(5):43-5. PubMed ID: 8279143
[TBL] [Abstract][Full Text] [Related]
36. [Changes in the lipid content of erythrocytes in patients with chronic renal failure].
Witkowska J; Bober J; Chlubek D
Ann Acad Med Stetin; 2007; 53(2):46-51. PubMed ID: 18557376
[TBL] [Abstract][Full Text] [Related]
37. The effect of low dose omega-3 on plasma lipids in hemodialysis patients.
Taziki O; Lessan-Pezeshki M; Akha O; Vasheghani F
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):571-6. PubMed ID: 17951945
[TBL] [Abstract][Full Text] [Related]
38. [Disordered lipid metabolism and the morphofunctional instability of the erythrocyte membranes in patients with terminal kidney failure].
Grinshteĭn IuI; Tereshchenko VP; Tereshchenko IuA; Romanova VIa
Ter Arkh; 1990; 62(6):84-8. PubMed ID: 2218935
[TBL] [Abstract][Full Text] [Related]
39. Plasma lipid patterns in chronic renal failure.
Lamberth EL; Oates JA
Trans Am Soc Artif Intern Organs; 1975; 21():473-8. PubMed ID: 1146020
[TBL] [Abstract][Full Text] [Related]
40. [Thermal energy balance during hemodialysis: the role of the filter membrane].
Panzetta G; Bianco F; Galli G; Ianche M; Savoldi S; Vianello S; Vidi E; Cicinato P
G Ital Nefrol; 2002; 19(4):425-31. PubMed ID: 12369045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
